Israel’s Together said on Thursday it signed a binding two-year deal worth at least $300 million to supply cannabis products to an unnamed Canadian company.

The Canadian firm will buy from Together subsidiary Globus Pharma 5 to 50 tonnes of dried cannabis inflorescences in 2019, which is equivalent to 500 kilograms to 5 tonnes of medical cannabis oil.

In 2020, the company, which has a licence to grow, manufacture and import medical cannabis in Canada, will buy another 20 to 50 tonnes of dried flowers, or up to 5 tonnes of cannabis oil.

It will pay at least $3 for 1 gram of dried inflorescences, or a minimum of $30,000 for 1 kg of cannabis oil, Together said.

Canada approved medical pot in 2001 and will legalize recreational use by July.

For long-term success, cannabis companies need to adopt technology as a critical capability.

Entrepreneurs in the cannabis industry are moving at warp speed to get their businesses up and running in time for the Canadian government’s legalization of adult-use cannabis, creating billions of dollars of value in the process. Most companies however, have failed to implement appropriate technology strategies during this boom, putting much of that equity at risk.

Keynote speaker at a health unit luncheon told companies there's no good test for impairment yet.

The Windsor Essex County Health Unit wants businesses to be prepared for the legalization of recreational marijuana.

It brought in a speaker Wednesday to speak to companies over the lunch hour.

"It's a timely and relevant topic that has implications for just about every workplace and the scenarios will be different everywhere depending on the kind of work," said Neil Mackenzie, manager of chronic disease and injury prevention with the health unit.

Already on the radar

Centerline was one of the companies attending and it says this is already on its radar.

The London-based medical grade cannabis producer is looking to expand production.

London's only medical grade cannabis producer, INDIVA has announced plans to expand, adding 30,000 square feet of space and dozens of jobs to its current 10,000 square foot growing and production facility. 

The announcement was made at an open house Wednesday at the company's high security facility in London's south-end. 

"We're in for a lot of growth, no puns intended," INDIVA co-founder, president and CEO Neil Marrotta said Wednesday. "We're up to 25 employees now, I think we'll get close to 50 by the end of the year." 

Marrotta said that INDIVA would also increase its production.

Vic Neufeld says advertising is the biggest barrier for his company going forward.

As the bill that will introduce the legalization of cannabis in Canada gets noodled around in Ottawa, one marijuana mogul said there's only one major barrier he's watching.

"One very simple one, and that's advertising."

Vic Neufeld is the CEO of Aphria — one of Canada's largest cannabis producers with facilities located in Leamington, Ont. His company has been expanding its medicinal and recreational cannabis production abilities, so he's been watching closely as Bill C-45 makes its way through the Senate and back to the House. 

The Liberal government and the Senate may be in the midst of a battle that further delays the legalization of recreational marijuana, but Cannabis NB is good to go with at least of one its stores.

The one in the north end of Saint John is now complete. Once the date for legalization is announced, Cannabis NB can stock the products and train the staff to be ready for opening day.

Brian Harriman, president and CEO of NB Liquor, hosted a tour of the new store with journalists, who took pictures and videos and asked questions about how the new stores will operate.

Legal recreational cannabis coming into effect in Canada has left a lot of employers feeling unprepared with how to deal with employees using marijuana at work.

Lorenzo Lisi and David Reiter, Partners at Aird & Berlis LLP spoke at the O’Cannabiz Conference and Expo in Toronto last week in a panel called Cannabis in the Workplace: Policies, Planning to Avoid Liability and Industry Stigma. The discussion provided insight on how to manage cannabis consumption in the workplace and how to accommodate those who require cannabis for medical use.

To create value, cannabis companies will need to navigate their way through a maze of possibilities.

As outlined in Chapter 2 of our series, building a successful business in the emerging cannabis sector begins with the creation of a coherent strategy for sustainable and profitable growth. However, a winning game plan alone is not enough. A company needs a combination of processes, tools, knowledge, skills and behaviours that rivals can’t match. An enterprise’s competitive position rests on this reinforcing system of differentiated and high-performing capabilities which management can leverage in pursuit of strategic paths.

Choom™ (CSE: CHOO) (OTCQB: CHOOF) (the "Company") is pleased to announce a non-brokered private placement for gross proceeds of up to $10,000,000, including a $7,000,000 lead order from Aurora Cannabis Inc.  The private placement will consist of up to 14,084,507 common shares at a price of $0.71 per share and is expected to close on June 18, 2018.

More cannabidiol oil production? Yes, please!

The Canadian marijuana industry is budding before our eyes, and last week's historic Senate vote is proof of this occurring. With a landslide vote of 56 in favor and only 30 against, Canada's Senate approved the Cannabis Act, sending the bill back to the House of Commons for confirmation. It's all but a formality at this point that adult-use cannabis will soon be legal in our neighbor to the north. 

For marijuana stock investors, the legalization of marijuana in Canada means one thing: dollar signs. Legalization means the addition of up to $5 billion in annual revenue on top of what the industry is already generating from domestic medical cannabis sales and exports to foreign countries where medical weed is legal.